Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

Shungo Imai; Satoru Mitsuboshi; Satoko Hori; Shigeaki Suzuki

doi:10.1016/j.ejca.2022.11.023

Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

Shungo Imai, Satoru Mitsuboshi, Satoko Hori, Shigeaki Suzuki

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1-3
Number of pages	3
Journal	European Journal of Cancer
Volume	180
DOIs	https://doi.org/10.1016/j.ejca.2022.11.023
Publication status	Published - 2023 Feb

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2022.11.023

Cite this

@article{f30b3476141c4391bfbec0c0270a3e9f,

title = "Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor",

author = "Shungo Imai and Satoru Mitsuboshi and Satoko Hori and Shigeaki Suzuki",

year = "2023",

month = feb,

doi = "10.1016/j.ejca.2022.11.023",

language = "English",

volume = "180",

pages = "1--3",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

AU - Imai, Shungo

AU - Mitsuboshi, Satoru

AU - Hori, Satoko

AU - Suzuki, Shigeaki

PY - 2023/2

Y1 - 2023/2

UR - http://www.scopus.com/inward/record.url?scp=85144751839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144751839&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2022.11.023

DO - 10.1016/j.ejca.2022.11.023

M3 - Letter

C2 - 36527972

AN - SCOPUS:85144751839

SN - 0959-8049

VL - 180

SP - 1

EP - 3

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this